Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma

We examined the role of positron emission tomography/computed tomography (PET/CT) in a retrospective study of 40 patients. Of the 40 patients, 90% had fluorine-18 fluorodeoxyglucose-avid findings on PET/CT at diagnosis. The interim PET/CT and end of treatment PET/CT results were not prognostic for progression-free survival (PFS) or overall survival (OS). On multivariate analysis, only lymphopenia remained prognostic for PFS and OS.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original Study Source Type: research